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ABSTRACT

Performance validity testing is a routine procedure used in neuropsychological
assessment to ensure an examinee is putting forth a performance that is an accurate
representation of their ability. There is increasing evidence that individuals reporting high levels
of psychiatric symptoms as well as those with mild traumatic brain injury (mTBI) fail
performance validity tests (PVTs) more often. This research sought to determine if the high base
rate of failure (BRFail) in the mTBI sample were related to an increase of self-reported
psychiatric elevations. An archival dataset of 480 individuals either with an orthopedic injury,
mTBI, or moderate-severe traumatic brain injury (msTBI) diagnosis (Dx) referred for
neuropsychological testing was retrospectively analyzed. Of the sample, 70.4% were male and
the average age was 39.3 years (SD = 11.9). Participants took part of a routine
neuropsychological assessment which included the Word Memory Test (WMT). Those in the
mTBI Dx group failed the WMT more often than those with msTBI. There was no interaction
between Dx and failing PVTs on psychiatric symptom reporting. Results did show a relationship
between Dx and PVT failure on some psychiatric symptom scales independently. Failing the
WMT was related to poorer outcome on neurocognitive tests. Overall, no interaction between
PVT outcome and Dx was found on self-reported psychiatric symptoms, each factor
independently explained a significant amount of variance. Results suggest clinicians should
continue to be aware of factors that may contribute to PVT failure in their practice, such as
elevated psychiatric symptom reporting and diagnostic group membership.

iv

ACKNOWLEDGEMENTS

I am incredibly grateful for the mentorship of my co-advisors, Dr. Laszlo Erdodi and Dr.
Christopher Abeare, not only for their contributions to this project but also their dedication to my
development as a future psychologist. To my committee members, Dr. Biss and Dr. Horton,
thank you for your invaluable feedback and input throughout this process. Also, I am grateful to
the late Dr. Paul Green for allowing me access to his archival data to complete this thesis. I am
lucky enough to have not one, but two, labs full of wonderful mentors and colleagues that have
also supported me in numerous ways.
I want to thank my parents for supporting me in every way possible throughout my life
and education. Thank you to my best friends for reminding about life outside of grad school and
to have fun throughout. To my cohort, I could not imagine going through this journey without
each and every one of you. Through in-person and online, your unwavering support, humour,
and much needed vent sessions have been much appreciated.
Lastly to my fiancé, Joshua, thank you for all of your love, reassurance, and your calming
presence throughout everything. Your drive and passion for your own field never ceases to
inspire me in my own. Thank you for your years of support and I look forward to a lifetime full
of it.

v

TABLE OF CONTENTS

DECLARATION OF ORIGINALITY.............................................................................................. iii
ABSTRACT ..................................................................................................................................... iv
ACKNOWLEDGEMENTS ...............................................................................................................v
CHAPTER 1 .................................................................................................................................... 1
Traumatic Brain Injury ............................................................................................................... 1
Neuropsychological Assessment ................................................................................................ 4
Performance Validity .................................................................................................................. 5
Symptom Validity Tests ............................................................................................................. 6
TBI and PVT Outcome ............................................................................................................... 7
Factors Influencing PVT Outcome ............................................................................................. 7
Psychiatric Symptoms and PVTs ................................................................................................ 8
The Influence of Psychiatric Symptoms on PVT Outcomes in TBI Populations ..................... 12
Cogniphobia .............................................................................................................................. 14
Somatization/ Cogniform Disorders ......................................................................................... 16
Psychogenic Interference .......................................................................................................... 17
The Current Study ..................................................................................................................... 18
CHAPTER 2 .................................................................................................................................. 20
Participants ................................................................................................................................ 20
Measures ................................................................................................................................... 21
Procedure .................................................................................................................................. 22
Data Analysis ............................................................................................................................ 23
CHAPTER 3 .................................................................................................................................. 24
Results ........................................................................................................................................... 24
Demographics ........................................................................................................................... 24
Psychiatric Symptom Report .................................................................................................... 25
Cognitive Performance ............................................................................................................. 33
Performance vs Symptom Validity across Diagnosis ............................................................... 35
CHAPTER 4 .................................................................................................................................. 36

vi

Discussion ..................................................................................................................................... 36
Cognitive Performance ............................................................................................................. 39
Clinical Implications ................................................................................................................. 40
Limitations and Future Direction .............................................................................................. 41
References ..................................................................................................................................... 44
Appendix ....................................................................................................................................... 61
Vita Auctoris ................................................................................................................................. 63

vii

CHAPTER 1
Introduction
Traumatic Brain Injury
Traumatic brain injuries (TBIs) are a leading cause of death and disability worldwide. It
has been estimated that 69 million people suffer from them each year (Dewan et al., 2019) and in
the United States alone it is estimated that 1.7 million TBIs occur each year with approximately
52,000 resulting in death (Faul et al., 2010). In Canada, about 0.5% of the 2014 population, or
approximately 175,000 individuals experienced a TBI each year and that between 2005-2014
there was a incidence of TBI more than doubled (Rao et al., 2017). The increased incidence of
TBI throughout the years was thought to be because of increased awareness and reporting of the
condition. Thus, both the incidence and awareness of this debilitating injury is high and
increasing over time highlighting the importance of research in this area.
TBIs are a complex and heterogenous because of the range of mechanisms of injury as
well as sequalae that can result. The current definition of TBI is an alteration of brain function or
other evidence of brain pathology due to an external force to the head (Menon et al., 2010). An
alteration of brain function includes post-traumatic amnesia, confusion, or disorientation after
injury, loss of consciousness (LOC) as well as any other neurological deficits such as changes in
sensory perception, loss of balance, and aphasia. In more severe cases, TBI could also result in
neuroradiologically confirmed damage to the brain, such as evidence of edema, hemorrhage, or
skull fracture in the acute stage. Long-term residual effects include atrophy, encephalomalacia
and disruption in white matter connectivity. The cause of TBI can range from blunt force to the
head, rapid acceleration-deceleration resulting in coup-countercoup injuries, projectiles
penetrating the brain, or acceleration/deceleration of the head causing damage. Therefore,
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although often grouped into one diagnostic category, TBIs include an expansive range of causes,
mechanisms, and outcomes.
Due to the wide range of TBI presentations and methods of injury, these injuries are
commonly classified into four severity groups: mild TBI (mTBI), mild complicated TBI
(mcTBI), moderate TBI (MTBI), and severe TBI (STBI). There are different criteria by which
severity classifications are made. One of the most widely used criteria is the Glasgow Coma
Scale (GCS) (see Table 1). Introduced in 1974 (Teasdale & Jennett), the GCS provides a
behaviorally based assessment of TBI. The observer provides rating on motor responsiveness,
verbal performance, and eye opening. Brain injury severity is indicated by a score between 3 and
15 with lower scores indicating lower responsiveness (STBI ≤8, MTBI 9-12, mTBI ≥ 13). Other
commonly used criteria include the duration of LOC or post-traumatic amnesia (PTA) (see Table
2). The differentiation between mTBI and mcTBI is the presence of positive neuroimaging
findings (bleeding, swelling or skull fractures) in the latter category (Iverson, 2005). However,
outcomes from mcTBI tend to more closely resemble those of MTBI (Kashluba et al., 2008).
The sequalae of TBI are heterogenous and expansive as they influence many broad
domains of cognitive and emotional functioning that typically vary based on the severity of
injury. For example, in mTBI, which encompasses between 70-90% of TBIs (Maas et al., 2017),
individuals often make a full recovery after experiencing negative symptoms for a few weeks. A
subset of mTBI patients continue to report symptoms beyond the normative window of recovery,
and utilize associated services (Bigler, 2008; King, Wade, & Beehler, 2014). This condition is
referred to as Post Concussive Syndrome (PCS). Patients with MTBI or STBI often have longterm cognitive, vestibular, behavioural and emotional repercussions that individuals with mTBI
only face short-term (if at all). The cognitive sequelae of TBI often include long-term and
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working memory impairment, difficulty with attentional/concentration and slowed processing
speed (Azouvi et al., 2017). Individuals often experience headaches and occasionally, other posttraumatic neurological disorders such as seizures (Annegers et al., 1998; Brown et al., 2015).
The emotional sequelae includes impairments with social cognition (Babbage et al., 2011), mood
regulation (Hanks et al., 1999) and increase of both diagnosed psychiatric/ mood disorders as
well as self-reported symptoms (Perry et al., 2016; Osborn et al., 2014; Osborn et al., 2016).
TBI and the Incidence of Self-Reported Psychiatric Problems
The relationship between TBI and psychiatric symptom reporting is especially important
because of the common increase of psychiatric problems seen after injury – either exacerbated
pre-existing conditions or newly onset. These psychiatric problems are evident in both formal
diagnosis (Perry et al., 2016) and in self-reported symptoms (Osborn et al., 2014; Osborn et al.,
2016). Patients with mTBI tend to report higher levels of psychiatric symptoms than those with
moderate and severe TBI (msTBI) (Osborn et al., 2014; Osborn et al., 2016).
This counterintuitive, but well-replicated finding is attributed to patients with mTBI
having more insight, less focus on cognitive repercussions, and fewer resources available to help
them than those with msTBI. Additionally, patients with TBI have a history of displaying
different psychiatric symptom self-reporting at different injury severity levels. On the Minnesota
Multiphasic Personality Inventory (Second Edition) (MMPI-2), a comprehensive self-report
inventory of personality and psychological functioning, patients with mTBI often report higher
elevations on the Hysteria (Hs), Hypochondriasis (Hy), Depression (De), and Psychasthenia (Pa)
scales than those with more severe brain injuries (Gass & Russell, 1991;Youngjohn, Davis, &
Wolf, 1997). This reverse dose-response relationship between injury severity and psychiatric
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symptoms runs counter to expectations. The leading explanations are the presence of genuinely
elevated psychopathology in the mTBI group or the PCS being similar to somatization disorder.
Neuropsychological Assessment
Due to the complex cognitive and emotional changes post TBI, individuals are often
referred for neuropsychological assessment to determine their level of functioning and estimate
the extent of residual deficits. Neuropsychological assessments contribute unique information
about functioning, above and beyond what current neuroimaging technologies provide, because
they determine how the injury affects the patient’s ability to perform cognitive tasks and by
extension, occupational and adaptive functioning. Neuropsychology is a diverse field of study
based on analysis of the brain-behaviour relationship. By utilizing psychometric tests, an
individual’s performance in various cognitive domains (attention, processing speed and memory)
is evaluated across sensory modalities (auditory, visual, tactile). Test behavior is quantified (i.e.,
number of correct answers, time taken to complete a task) and then compared to a normative
sample to determine the individual’s relative standing. The pattern of performance across
different tests provides insight on the examinee’s overall level of functioning, and severity of
neurocognitive deficits. This information is used in a broader context for diagnostic
consideration, to optimize the clinical management of the underlying condition and injuries such
as TBI, and provide suggestion for helpful treatments and therapies.
TBIs often involve changes in emotional functioning as well. Therefore,
neuropsychologists also assess for psychiatric symptoms, using structured symptom inventories
and clinical interviewing of both the patient and collateral informant. A comprehensive
neuropsychological evaluation includes assessments of psychopathology because there is
research suggesting emotional functioning can influence cognitive outcomes (Eysenck et al.,
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2007; Owens et al., 2008; Qureshi et al., 2011; Rock et al., 2014; Ross et al., 2003; Samuelson et
al., 2006; Scott et al., 2015; Snyder, 2013), neurological conditions have emotional sequalae, and
psychopathology can affect participation in rehabilitation therapies, therefore the assessment of
psychopathology is relevant to rehabilitation efforts.
Performance Validity
Throughout neuropsychological assessment, interpretation of test results rests on the
assumption that the examinee’s test performance is an accurate representation of their true ability
level (Larrabee, 2012; Bigler, 2015). The importance of valid responding is typically conveyed at
the beginning of the assessment, when examinees are instructed to “perform at the best of their
abilities.” This request has long been interpreted as an implicit verbal contract that ensured valid
performance. This posed an issue as there are many reasons why one may not be able or willing
to perform to the best of their abilities. Although the underlying reasons for non-credible
presentation are often unknown to the clinician and ultimately irrelevant (Merten &
Merckelbach, 2013), implementation of objective measures of symptom and performance
validity monitoring have gained use in recent years.
Performance Validity Tests
The uncertainty of performance validity within neuropsychological assessment poses a
risk to the interpretation of results. Determining the credibility of the patient’s presentation
during the assessment based on clinical judgement alone has long proven to be ineffective
(Heaton et al., 1978). Therefore, performance validity tests (PVTs), which are objective
measures of the credibility of a given response set, have been endorsed by major professional
organizations (Committee on Psychological Testing, 2015). PVTs are tests calibrated so that

5

patients with severe bona fide neurologic and psychiatric problems (Heilbronner et al., 2009) can
pass them.
PVTs can either be free-standing or embedded instruments. Free-standing PVTs are
measures that were created with the intended purpose of monitoring performance validity,
providing little to no information on cognitive ability. Embedded validity indicators (EVIs) are
instruments derived from existing neuropsychological tests that are then subsequently co-opted
to give a measurement of performance validity (Committee on Psychological Testing, 2015).
PVT failures indicate that the overall neurocognitive profile likely underestimates the
examinee’s true ability level (Larrabee, 2012), without providing any information about the
underlying reason (Boone, 2013). Currently, PVTs have gained use as objective empirical
methods to evaluate performance validity and are now considered standard use in clinical
practice (Chafetz et al., 2015).
Symptom Validity Tests
Symptom validity tests (SVTs) are measures designed to monitor the validity one’s
symptom reports. Individuals self-reporting psychiatric symptoms may not be presenting
themselves in an accurate manner, and personality inventories on are often unhelpful on their
own in separating genuine and exaggerated symptoms (Boone, 2007). For this reason, SVTs
have been implemented in self-report symptom scales in order to assess for response bias.
There is conflicting evidence on the relationship between SVTs and PVTs. Some studies
suggest that they are independent of one another (Demakis, Gervais, & Rohling, 2008; Nelson,
Sweet, Berry, Bryant, & Granacher, 2007; Ruocco et al., 2008), while others found that patients
who fail PVTs are more likely to over-endorse symptoms (Haggerty, Frazier, Busch, & Naugle,
2007; Mathias et al., 2002; Whiteside, Dunbar-Mayer, & Waters, 2009; Jones et al., 2012). A
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confirmatory factor analysis performed by Van Dyke and colleagues (2013) to determine the
relationship between performance validity and symptom validity tests found that symptom
validity, performance validity and cognitive abilities were independent factors.
TBI and PVT Outcome
Due to the medicolegal context of TBIs (i.e., personal injury litigation, disability claims,
somatization), PVTs are essential during neuropsychological assessment. Paradoxically, base
rates of PVT failure rate (BRFail) has a reverse dose-response relationship to TBI severity, much
like psychiatric symptom reporting: mTBI is associated with higher BRFail than more severe TBI
(Donders, Lefebre & Goldsworthy, 2019; Abeare et al., 2019; Carone, 2008; Erdodi & Rai,
2017; Green, Flaro, & Courtney, 2009; Green, Iverson & Allen, 1999). This finding is
counterintuitive, as severely injured individuals typically perform worse on measures of
cognitive ability. PVTs, however, are known to be insensitive to genuine impairment (Critchfield
et al., 2019) so the true mechanism of this reverse dose-response relationship is poorly
understood. The issue is further complicated by the ubiquity of this phenomenon: it is observed
in both medico-legal and clinical contexts, suggesting that external incentive to appear impaired
does not fully explain the elevated BRFail in mTBI.
Factors Influencing PVT Outcome
Effort and engagement during neuropsychological assessment is a dynamic process and
many factors can contribute to one’s ability to demonstrate valid performance. Malingering
(intentional suppression of test performance in the presence of external incentives to appear
impaired; American Psychiatric Association, 2013) is the most researched etiology for PVT
failure. Genuine and severe impairment can also account for PVT failures, such as dementia and
intellectual disabilities (Dean et al., 2008; Dean et al., 2009; Smith et al., 2014). These diagnostic
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categories are considered exempt from PVTs, although recent investigations identified specific
instruments with low false positive rates even in these populations (Messa et al., 2020).
In addition to neurological diagnoses, there are other reported influences on performance
validity in the literature. For example, individuals with limited English proficiency (LEP) and
patients with aphasia have higher failure rates on PVTs with high verbal mediation, likely due to
focal impairment in language (Ali et al., 2020; Bodner, Merten & Benke, 2019; Erdodi et al.,
2017). Language dominance was able to explain between 6-31% of the variance in passing or
failing PVTs with high verbal mediation (Erdodi et al., 2017).
In undergraduate populations, it is surprisingly common to see PVT failures because
there is a lack of incentive to demonstrate their full ability (An et al., 2017; Roye et al., 2019).
Additionally, in this population, there is motivation to finish testing as quickly as possible which
could also result in PVT failure (DeRight & Jorgensen, 2015). Even when incentivized to
perform well, university students fail PVTs (Abeare et al., 2021) at rates comparable to clinical
and even forensic settings (Young, 2015; Larrabee, Millis, & Meyers, 2009) – a phenomenon
that lacks a coherent explanation.
Somatic disorders, where emotional distress is expressed as physical symptoms that cause
disruption in daily life, have also shown to inflate BRFail. Patients with medically unexplained
symptoms also often fail PVTs (Kemp et al., 2008), although results diverge across studies,
instruments and populations (Tyson et al., 2018).
Psychiatric Symptoms and PVTs
Another key factor explored in the literature is the influence of a psychiatric symptoms
on performance validity. It has been documented in the literature that specific disorders such as
depression (Rock et al., 2014; Snyder, 2013), anxiety (Owens et al., 2008; Eysenck et al., 2007),
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PTSD (Scott et al., 2015; Qureshi et al., 2011; Samuelson et al., 2006), schizophrenia (Heinrichs
& Zakzanis, 1998; Heaton et al., 2001) influence cognitive test scores. These psychiatric
disorders may interfere with cognitive processes that can lead to lower overall test scores.
Additionally, individuals can have a psychiatric condition that manifests in a way that it presents
itself as a neurodegenerative disease otherwise referred to as “pseudodementia” (Heaton et al.,
2001). The literature has not been consistent on whether or not these symptoms influence the
outcome of performance validity testing.
Recent research has found evidence that psychiatric symptoms are related to PVT
outcomes. Erdodi et al. (2017) showed in a mixed clinical sample there were moderate
associations between failures on the Grooved Pegboard Test as a PVT and self-reported
depression and anxiety. Miskey et al. (2019) found that failure on memory-based (but not
attention-based) PVTs was related to PTSD severity. Marcopulos et al. (2014) found that a
sizeable proportion (11%) of their psychiatric sample failed PVTs in the absence of external
incentive to underperform. These individuals were more likely to be female, have less education
and have a diagnosis of schizophrenia.
Past research has not always supported this notion as, for example, Ashendorf et al.,
(2004) found that those that self-reported depression and anxiety was unrelated to PVT outcome
across both trials. Similarly, Considine et al., (2011) found there was no difference between
those diagnosed with Major Depressive Disorder (MDD) and healthy controls on either trials of
the Test of Memory Malingering (TOMM). In different severity levels of depressed older adults
(mild, moderate, severe as diagnosed by clinical interview), Lee et al. (2000) did not find any
differences on the Dot Count Test or the Rey-15 item test.
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Merten and Merckelbach’s 2013 paper argued that attributing PVT failures to psychiatric
symptoms is weakly supported because these psychiatric symptoms usually cause minimal
interference in the person’s daily life. They stated that any PVT failure that cannot be explained
by outright malingering should just be considered poor cooperation as there is no convincing
evidence the disorder itself can cause failure and is likely linked with external incentives. Merten
and Merckelbach suggest psychogenic interference as an exculpatory explanation for PVT
failures, “poor cooperation” is an ill-defined construct. However, Wise & Smith (2011) outline
that engagement in testing is made up of many intrinsic and extrinsic factors that can contribute
to one’s effort during assessment. Generalizing all of these factors into poor cooperation is
overly reductionistic, as it discounts the complexity of human behaviour and specific reasons an
individual may not be fully engaged in testing.
Merten & Merckelbach’s claim that an individual’s psychiatric symptoms create minimal
interference in their daily lives may be true, but that does not indicate it never plays a factor in
their functioning. It is well documented that in some psychiatric conditions, including anxiety,
PTSD, and depression, that individuals practice avoidance behaviours in their daily lives to
minimize their ongoing symptoms (Badour et al., 2012; Ottenbreit & Dobson, 2004; Aderka et
al., 2013). By tailoring their daily life to adapt to the hardship of living with these symptoms,
individuals are often creating less interference of their symptoms day-to-day.
Neuropsychological assessment, however, could be a more stressful and anxiety provoking
environment where the individual is confronted with new cognitive demands, must follow a rigid
set of rules in order to complete the assessments. Therefore, what is minimally invasive in their
daily lives might not be in this unique setting designed to evaluate one’s global
neuropsychological functioning. Of course, evidence to the contrary has also been widely
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mentioned in the clinical literature. Namely, laboratory-based tests have limited ecological
validity because of the structured, distraction-free, and supportive environment in which they are
administered. Essentially, one cannot be sure if the individual being assessed would perform
better or worse in real-life situations. Therefore, the argument that there is minimal interference
in the testing environment from psychological symptoms may be overly simplistic.
Lastly, their argument does not address specific cases such as individuals with TBI that
often display a complex relationship between cognitive and emotional functioning. A key factor
in the aforementioned studies that found no link between psychiatric and performance on PVTs
is that they were performed in otherwise healthy populations. In TBI populations, individuals are
uniquely dealing with a combination of cognitive and emotional symptomatology that can
complicate their ability to perform on neuropsychological assessments. One study on veterans
with mTBI and PTSD found that they performed significantly worse on cognitive measures than
those with mTBI or PTSD alone (Combs et al., 2015). A similar effect is often reported with
depression, as they work in an additive fashion with TBI and can compound severity over and
above a typical TBI profile (Schultz et al., 2018). This indicates there may be some form of
additive effect of psychiatric symptomatology with TBI that causes greater levels of impairment
than expected based on their neurological injury alone. Additional support for this was found in
Stenberg (2020) where mTBI patient’s self-reported cognitive symptoms were highly related to
their emotional and somatic symptoms and unrelated to their actual cognitive performance. This
underscores the point that in a brain injury sample, a complex interaction between cognition and
emotional functioning can influence perceived recovery. Nonetheless, it is unclear why this
additive effect occurs, but emotional factors such as all-or-none thinking, anxiety, depression and
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stress have been found in those who have a prolonged recovery from PCS (Hou et al., 2012;
Ponsford et al., 2012).
The Influence of Psychiatric Symptoms on PVT Outcomes in TBI Populations
The interaction between cognitive and emotional functioning after brain injury has been
shown to influence test scores. In fact, in a TBI sample Udala et al. (2019) discovered specific
domains of cognitive functioning that were correlated to increased self-reported symptoms on the
MMPI-2. Higher scores on Psychasthenia, Schizophrenia, Obsessions, and Bizarre Mentation
predicted lower scores on list learning measures. A higher rating of the Fears subscale predicted
a lower working memory score. Higher endorsement of Schizophrenia scale was related to lower
verbal memory test scores. Lastly, higher scores on the Depression scale predicted a lower
visuographic memory score. This study uniquely demonstrates that within a TBI population,
specific psychiatric self-reported symptoms is predictive of lower cognitive functioning,
however, does not answer if these low scores translate to PVT failure.
In 2018, Erdodi and colleagues found that a TBI sample that failed a forced-choice
recognition PVT reported higher levels of psychiatric symptoms. Another study by Erdodi et al.,
(2019) found that failing the Word Memory Test (WMT), a free-standing PVT, was associated
with self-reported level of depression in a mTBI sample. In both studies however, they failed to
account for the validity of reported psychiatric symptoms. As such, it is unclear whether
elevations reflect genuine distress or exaggerated symptom report.
Another study demonstrated that a dual diagnosis of TBI and PTSD was associated with
higher BRFail than TBI and subsyndromal PTSD. It is thought that their complex trauma may
have caused more risk of failure (Greiffenstein & Baker, 2008). Due to the fact that there was no
PTSD-only group, it is uncertain if this effect would occur in the absence of TBI as well. Clark et
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al., (2014) also found that veterans who failed PVTs had increased rates of clinical diagnoses of
TBI, PTSD, or comorbid TBI/PTSD, along with depression and substance use. Additionally,
they discovered that those who reported more severe symptoms on self-report rating symptom
scales also had higher BRFail. It is important to note that in both these studies those who failed
SVTs were not excluded. Overlap between PVT and SVT failure was identified therefore PVT
failure cannot be attributed to the dual diagnosis alone (Clark et al., 2014).
Erdodi et al. (2016) investigated the BDAE Complex Ideation Material as a PVT and
showed that not every group that displayed a complex psychiatric history or emotional distress
had increased PVT failure rates. In particular, those that were categorized as having PCS
(cognitive complaints past the 3-month recovery window) which included individuals with
comorbid psychiatric conditions showed a much higher PVT failure rate. BRFail was higher for
the PCS group than those with non-PCS psychiatric features such as those with psychogenic nonepileptic seizures. These results, again, demonstrate a unique relation between those with TBI
and comorbid psychiatric symptoms showing invalid performance even in comparison to other
psychiatric groups.
A study by Jurick et al. (2019) reported on PVT failure rates in 100 veterans with
comorbid PTSD and TBI. The goal was to determine if individuals with PTSD symptoms that
failed PVTs benefited from psychotherapeutic intervention for those symptoms and improved
PVT failure outcome. The authors found that both PVT pass and fail groups had reduced PTSD
symptoms after intervention. BRFail was lower after treatment, suggesting a link between
emotional distress and PVT failure.
Another similar study reported on a sample of 411 veterans with mTBI with the goal of
characterizing the cognitive concerns of veterans after mTBI and to inspect their
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neuropsychological profiles (Jak et al., 2019). They found that a third of the sample failed PVTs;
these veterans were more likely to have a psychiatric diagnosis such as PTSD and depression.
Additionally, self-reported PTSD, depression, anxiety and neurobehavioral symptoms were also
higher in the PVT failure group. This work is important as it further supports the argument that
individuals that fail PVTs with TBIs are more likely to have elevations on self-reported
psychiatric symptom scales.
Sherer et al., (2020) utilized cluster analysis to inspect clinically meaningful subgroups of
those who failed PVTs in a TBI population. They identified three clusters: subgroup 1 had
problems with memory but no excess complaints, subgroup 2 had impaired memory and
processing speed with cognitive and emotional complaints and subgroup 3 had impairment in all
domains and elevated emotional and cognitive complaints. It is apparent that in a majority of the
groups, there was significant self-reported emotional/psychiatric distress. This study, however,
did not control for litigation status or utilize symptom validity tests. This means that it is
unknown if there are other factors involved in the PVT failure such as external incentive or if the
distress they are reporting is credible. Also, this study did not offer a non-TBI control group,
meaning these clusters may not be unique to the TBI population.
Cogniphobia
In addition to the literature on self-reports of general psychiatric symptoms (depression,
anxiety, PTSD etc.) other forms of emotional distress, such as cogniphobia, have also been
shown to be linked to PVT failure. The phenomenon occurs when individuals that have a history
of headaches (either migraines or headaches after TBI) do not exert the cognitive effort
necessary to perform to the best of their abilities due to fear of bringing on or exacerbating their
headaches. This phenomenon was based off of a similar phenomenon that occurs with general
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bodily injury called “kinesophobia” where an individual has a fear of moving because they do
not want to make their physical pain worse. Kinesophobia has been shown to decrease
performance on physical tasks (Trost, France, & Thomas, 2011) and the effect can be present
whether or not pain actually comes from the activity. Martelli et al., (1999) were the first to
expand the phenomenon to cognitive performance and individuals with headaches. This fear of
headaches could be a motivating factor in withholding some cognitive effort, resulting in lower
neuropsychological test performance.
Suhr & Spickard, (2012) found that fear of headache onset was associated with lower
scores on a measure of sustained attention in a population of undergraduates that experience
frequent headaches. Those who failed the WMT were more likely to have high scores on the
fear/avoidance measure of cogniphobia. However, the authors were unconvinced these findings
were accurately showing that those with cogniphobia failed PVTs more often. This was because
when removing those who failed the WMT, there was still an effect of fear/avoidance on
cognitive performance. Silverberg, Iverson & Panenka (2017) found that failing the Medical
Symptom Validity Test (MSVT) a PVT was associated with fear/ avoidance of exerting mental
effort. The effect was also found for other memory based cognitive measures. Those that
reported avoiding mental exertion also avoided physical activity and traumatic stressors, which
suggests that cogniphobia may be linked to a broader style of avoidant coping.
Henry and colleagues (2018) identified three factors that influenced performance validity,
particularly in their TBI population: cogniphobia, attribution of their symptoms to their injury,
and forensic context. This research regarding the complex relationship between the sequalae of
brain injury and fear of exacerbating symptoms through mental exertion, further underscores the
point that many factors involving an individual’s own distress, beliefs and attributions, and
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context can influence performance on neuropsychological assessment as well as their outcomes
on PVTs.
Somatization/ Cogniform Disorders
In addition to cogniphobia there is another phenomenon, termed cogniform disorder, that
occurs when cognitive impairment not explained by medical findings appears due to emotional
distress. The phenomenon is similar to somatic symptom disorder within the DSM-5 where
individuals have an extreme focus on physical symptoms (commonly pain or fatigue) causing
distress and dysfunction in their daily lives. Somatic symptom disorder however, focuses on
physical symptoms and anxiety related to those physical manifestations and dismisses any
cognitive manifestations. Due to the limitation of that diagnosis, Delis and Wetter (2007) coined
the term cogniform disorder (and the less pervasive subtype, cogniform condition) to encompass
the cognitive presentation of the disorder. Cogniform disorder occurs when an individual that
reports cognitive complaints and also shows low scores on cognitive testing which is not
otherwise accounted for by medical or psychiatric conditions. Their main primary complaint is of
cognitive changes, and in addition to their low cognitive scores they also have some kind of
impairment in their daily life. As well, they exhibit an abnormal degree of worry about their
cognitive impairment and there is lack of evidence that their low scores were produced
intentionally. Therefore, it is thought that the individual’s cognitive complaints and poor
performance are an unconscious conversion reaction that manifest as cognitive problems
(Kosaka, 2003). Cogniform disorders can also occur alongside neurological disorders such as
TBI. In these cases, however, the impairment must be severe over and above what could be
expected from the brain injury to be considered as cogniform disorder. For someone with an
mTBI this could be, for example, loss of the ability to perform over-learned skills such as

16

reading, spelling or simple math (when the individual was able to do so prior and there is no
history of a learning disorder). This disorder captures these phenomena that although one’s
injury may not be pervasive enough to cause impairment, there are other psychological
mechanisms that can lead to impaired presentation in neuropsychological test data. Within the
symptoms of this condition, failing PVTs is a criterion for the disorder therefore, when
investigating the failure rate of those with mTBI, cogniform disorder warrants consideration.
Psychogenic Interference
The combination of psychological factors discussed above that are related to BRFail are
heterogenous ranging from formal diagnoses of a disorder (Greiffenstein & Baker, 2008), selfreport of psychiatric symptoms (Erdodi et al., 2018), fear of cognitive exertion bringing on
physical symptoms (Suhr & Spickard, 2012), and distress about one’s cognitive symptoms overand-above what is to be expected from injury (Delis & Wetter, 2007). This results in a noncredible pattern of deficits, meaning the individual would be identified as giving an invalid
performance which may mean they are presenting as more impaired than what is to be expected
based on their cognitive abilities. The concept of emotional distress influencing
neuropsychological testing (i.e. PVT outcomes) was explored in 2016 when Erdodi and
colleagues found that individuals with a heterogenous display of psychiatric concerns (complex
trauma, somatic concerns) failed PVTs at a very high rate (61-93%) in comparison to the
expected 30-50% failure rate in a forensic setting (Martin et al., 2015). This phenomenon of
psychological distress interfering with mental performance was referred to as “psychogenic
interference” by the authors. Instead of focusing on exact psychiatric symptoms that potentially
are interfering with neurocognitive performance, this term encompasses all episodes of
emotional disturbance that could potentially be linked to PVT outcomes. Also, instead of
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hypothesizing the reason for why each set of symptoms increase could potentially be linked to
PVT failure just the knowledge that if there broadly is some form of distress it could be a factor
in PVT failure holds clinical utility.
The Current Study
This research seeks to determine if the high BRFail in the mTBI sample is related to an
increase of self-reported psychiatric elevations. The goal is to determine if there is a link between
injury severity, psychiatric elevations, and PVT failure. The results of this study will provide
important information on how factors outside of those already discovered (LEP, motivation) may
influence outcomes on PVTs. It will also give insight into the perplexing phenomenon of the
“reverse-dose response” relationship of TBI severity and PVT failure. The preceding literature
review highlights a gap in the current neuropsychological literature and offers no explanation to
the question of why individuals with mTBI have higher BRFail. The literature also suggests that
patients with mTBI often report higher levels of psychiatric symptomatology than those with
msTBI. Therefore, research is warranted to examine if there is a link between PVT failure and
self-reported psychiatric symptoms and if this differs across injury severity levels.
In previous work there are inconsistencies that make results difficult to interpret. In many
cases, researchers are not utilizing symptom validity testing, meaning they cannot be sure if
respondents are accurately representing their self-reported symptoms. When utilizing selfreported measures of psychiatric symptomatology it is important to validate whether the claims
of the respondent are valid. It has been repeatedly shown that individuals who are seeking
compensation following mTBI engage in symptom over-reporting (Greiffenstein & Baker,
2008). To ensure we are getting an accurate estimation of their psychiatric pathology those who
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fail SVTs will be grouped separately for analysis of the relationship between psychiatric
symptoms and PVT outcome.
Also, much of the previous research focuses on linking PVT failures with full diagnoses
of psychiatric disorders or other metrics such as previous history of psychiatric treatment
(Donders et al., 2019). In this research, we will focus on self-report of broad psychiatric
symptoms that can be classified under multiple disorders by using the MMPI-2. This
classification of psychiatric symptoms is being used because it assesses what the individual is
feeling close to the assessment time and it will capture psychiatric elevations that may otherwise
be dismissed as “subclinical” or not meeting full criteria if basing our research on clinical
diagnosis.
Although similar work has shown validity and clinical scales on the MMPI-2 correlate
with PVT outcomes and SVT failure was more common in mTBI (Thomas & Youngjohn, 2009),
the proposed study improves on this finding in multiple ways. In addition to having a
substantially larger sample size, this research uses a comparison group of orthopedic controls.
This control group is important because it will determine if the phenomenon is unique to
individuals with TBIs including some form of alteration of cognitive and emotional functioning,
or if increases of self-reported psychiatric symptoms is correlated with PVT failure even without
head injury. This will indicate whether the findings are specifically related to TBI or to injury in
general. We will also inspect cognitive functioning on a range of neuropsychological measures
between PVT groups. This will inform us if cognitive tests scores are also different between the
diagnostic categories and PVT failure groups.
The first research question is whether those with mTBI have a higher BRFail than those
with msTBI or orthopedic patients. This control group adds a unique opportunity to match
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participants on their level of distress from a previous injury but compares between those with
TBI and those without. It is expected that similar to previous research findings, those with mTBI
will fail PVTs more often than those with msTBI. It is hypothesized that because individuals
within the orthopedic control group should be cognitively intact and have less psychiatric
symptoms, they should have the lowest BRFail.
The second research question is whether individuals with higher self-reported psychiatric
symptoms have higher BRFail than those with lower reported symptoms. It is expected from
previous research that those who fail PVTs will have higher self-reported psychiatric symptoms
on the MMPI-2.
The third research question is whether BRFail on PVTs across injury severity is related to
self-reported psychiatric symptoms. Based on research examining each phenomenon separately,
it is hypothesized that individuals who fail PVTs will be more likely to be in the mTBI group and
also have higher levels of self-reported psychiatric elevations.

CHAPTER 2
Method
Participants
A dataset of 480 total individuals referred for neuropsychological or psychiatric
assessment was collected by a clinical neuropsychologist within their private practice in Alberta,
Canada. Participants were referred from a range of sources including Workers Compensation
Board, Insurance, Legal, Doctors, Private or other specific occupational referrals. Individuals
were separated into three diagnostic groups, orthopedic injuries (n=41), mTBI (n=346), and
msTBI (n=93), based on their injury severity characteristics (GCS, PTA). The resultant sample
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size was deemed to be sufficient based on G*Power analysis and studies on similar previously
published data undertaking similar analyses across TBI severity (Abeare et al., 2019).
Measures
Minnesota Multiphasic Personality Inventory- 2 (Hathaway & McKinley, 1989) This
measure was used for both the Clinical Scales and the validity scales embedded within the
measure. The notable Clinical Scales used were outlined by Gass et al., (2017) as
Hypochondriasis (Hs), Hysteria (Hy), Schizophrenia (Sc), Hypomania (Ma), Psychopathic
Deviate (Pd), Paranoia (Pa), and Depression (De). The F scale was utilized as a proxy for
symptom validity due to accessibility of the data. Although some reports indicate that the F scale
is not as effective of SVT as the Fake Bad Scale (specifically in TBI populations due to the lack
of somatic related items in the scale), other resources have found that it was able to identify TBI
patients considered to be malingering under the Slick, Sherman and Iverson criteria (1999) with
AUC of 0.79 and positive predictive powers between 0.78-0.88 (Greve et al., 2006). Therefore,
for purposes of this research it was utilized as the main SVT.
Beck Depression Inventory- II (Beck, 1996) This questionnaire includes questions related
to the affective, cognitive and somatic symptoms of depression and was used as a measure of
self-reported depression.
Word Memory Test (Green, 1995) This measure is a free-standing performance validity
measure that utilizes recall of previously seen words to determine if individuals are giving a
valid performance. It has been independently validated in TBI populations (Green et al., 1999).
California Verbal Learning Test (Delis, Kramer, Kaplan & Ober, 1987) The California
Verbal Learning Test (CVLT) is a list learning task that assesses an individual’s learning abilities
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over multiple trials. The scores that were utilized in this study are acquisition trial scores (CVLT
1-5), Long Delay free recall (CVLT LD) and recognition trial (CVLT RH).
Grooved Pegboard Test (Matthews & Klove, 1964) The Grooved Pegboard Test is a
measure of manual dexterity, specifically fine motor speed. The participant is asked to put
grooved pegs into angled slots as quickly as possible one at a time, incorporating a heavy spatial
component along with the fine motor skills.
Finger Tapping Test (Reitan, 1969) The Finger Tapping Test (FTT) is a test of motor
functioning that requires participants to tap a lever attached to a mechanical counter using their
extended index finger for ten seconds at a time, over at least five consecutive trials. This
procedure is then repeated for the non-dominant hand. Once the FTT is completed, the trials are
averaged, which is then used as the summary score each hand (dominant and non-dominant)
hands.
Trail Making Test (Reitan,1955) The Trail Making Test (TMT) is a test of attention,
visuomotor and executive functioning. It has two parts, the first where the participant must
connect numbers in sequence on a page. The second where the participant must connect numbers
and letters in order on the page which has a greater focus on executive functioning skills and setshifting skills.
Procedure
Participants were referred for neuropsychological assessment at a private practice in
Alberta, Canada. Sessions were completed by a trained psychometrist in either one session or
multiple sessions based on the individual needs of the patient. Assessment sessions consistent of
different measures, depending on the clinical objective of the assessment. Data was compiled
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over a 9-year span and retrieved by researchers at the University of Windsor for retrospective
analyses.
Data Analysis
This was a case control design, as those with mTBI, msTBI, and an orthopedic control
were compared with regard to psychiatric elevations and PVT failure. Independent t-test was
used to analyze PVT failure group differences in neurocognitive test outcomes. ANOVA was
conducted to test for diagnosis group differences on neurocognitive test scores to demonstrate
external validity of previous results. Scores on the GPB, FTT, TMT were corrected using
demographically adjusted norms by Heaton et al. (2004). When relevant, the base rate of failure
(BRFail) were used convey the percent of the sample that failed the PVT.
For the analysis of scores on psychiatric self-report scales (MMPI-2 or BDI-II) a twoway ANOVA (Analysis of Variance) with pairwise post hoc contrasts was used. This method
allowed both the main effects of diagnosis (Dx) and WMT outcome on psychiatric symptom
report to be analyzed as well as the interaction between these two independent variables.
Independent sample t-tests were used to compare the effect of WMT outcome on psychiatric
symptom reporting at each diagnosis level. To determine if there was a difference on cognitive
test performance (CVLT, TMT, GPB, FTT) between the diagnostic groups, a one-way between
subjects ANOVAs were performed. All post hoc pairwise contrasts were uncorrected as
emphasis was put on effect size allowing readers to evaluate the clinical significance of group
differences without relying on p-values.
Effect size estimates are expressed in partial eta squared (η2p) and Cohen’s d (d).
Independent sample t-tests (two-tailed) were used to analyze the effect of WMT outcome on
cognitive test scores. A chi-squared test of independence was utilized to inspect of
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passing/failing PVTs was related to passing/failing of SVT (MMPI-2 F Scale) with effect size
estimates expressed in phi squared (Φ2). Prior to conducting the ANOVA, the assumptions of
normality, and homogeneity of variance were evaluated. The assumption of normality was
violated for the tests, however, homogeneity of variance was not. Due to ANOVA being robust
to violations of normality, especially when sample size is large and homogeneity of variance is
not violated (Tabachnick & Fidell, 2013), the analyses were continued.

CHAPTER 3
Results
Demographics
Data for a total of 480 participants was received from an archival dataset. Clients were
administered different psychiatric and neuropsychological measures depending on their referrals,
resulting in small fluctuations in group size between measures. Overall, 70.4% of the participants
were male, 90.9 % were right handed, the mean age was 39.3 years (SD = 11.9), and the mean
number of years of education was 12.0 (SD = 2.6). In this group, 91.0% of participants identified
as having English as their first language. There were no significant age differences among the
diagnostic groups: orthopedic (M = 40.0, SD = 11.7), mTBI (M = 39.6, SD = 11.7), msTBI (M =
37.7, SD = 12.4), F(2) = 1.06, p = .374, η2p=.004 [small effect]). There were also no education
difference between groups: orthopedic (M = 12.1, SD = 2.0), mTBI (M = 12.1, SD = 2.7), msTBI
(M = 11.8, SD = 2.5), F(2) = 2.45. p = .700, η2p = .001 [small effect]). There was a significant
difference for age between those who passed (M = 38.2, SD = 11.7) and failed (M = 41.9, SD =
12.0) the WMT t(477) = 3.06, p = .002, d = 0.31 (small effect) as well as a significant education
difference between those who passed (M = 12.3, SD = 2.6) and failed (M = 11.5, SD = 2.6)
PVTs t(477) = 2.89, p = .004, d = 0.31 (small effect).
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Psychiatric Symptom Report
Analysis using a 2-way factorial ANOVA was conducted to determine the influence of
the two independent variables (Dx and Pass/ Fail status on the WMT) on psychiatric symptom
reporting. Significant main effects for Dx were found for BDI-II, MMPI-2 Hs, Hy scales (Tables
1 to 8). Significant main effects for WMT outcome were found for MMPI-2 Hs, De, Hy, and Ma
scales. There was no interaction between the WMT and Dx for any of the psychiatric symptom
report scales (Tables 1 to 8). Independent sample t-test revealed higher levels of psychiatric
symptom reporting on all scales for those who failed the WMT in the mTBI group (d: 0.250.58), except for the Ma scale. In the orthopedic group there were higher levels of symptom
reporting on the Hy, Hs, and Ma scales for those who failed the WMT.
Post hoc tests revealed significant differences only on the BDI-II between the mTBI and
msTBI groups that failed the WMT (d = 0.80; large effect). On the MMPI-Hs scale, a significant
difference was observed between mTBI and msTBI groups that passed the WMT (d = 0.36;
small effect). On the MMPI-Hy scale, there were significant post hoc contrasts for some levels
of Dx and WMT pass/fail status (d: 0.46- 1.46; medium-large effect). This excluded the
orthopedic and mTBI group that passed the WMT as well as the mTBI and msTBI group that
failed the WMT.
Analyses were recomputed after removing patients who had failed the MMPI F Scale in
order to determine if non-credible psychiatric symptom reporting contaminated the analyses. The
resulting outcomes remained the same when removing those who failed SVTs, except the main
effect of Dx on the BDI-II outcome was no longer present.
The BRFail on the WMT differed across Dx on both the BDI-II [χ2 (2, N = 414) = 7.50, p =
.023, Φ2 = .018 (small effect; Table 1)], and the MMPI-2 [χ2 (2, N = 462) = 8.27, p = .016, Φ2 =
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.018 (small effect; Tables 2-7)]. Patients in the mTBI group failed the WMT at a higher rate
(31.5 %) compared to msTBI group (19.6 %) but not when compared to the orthopedic group
(12.9 %): χ2 (1, N = 439) = 4.88, p = .027, Φ2 = .011 (small effect).

Table 1
Factorial ANOVA Examining the Effect of Diagnostic Group and WMT Outcome on Scores on the Beck
Depression Inventory-2
Diagnostic Groups
Outcome Measure
1
2
3
BDI-II
ORTHO mTBI
msTBI
Sig. Main Effect
Fail
n = 22
n = 308
n = 84
ANOVA
post Pass
SD M
SD M
SD Effect
F
p
η2p
hocs d
d
WMT M
Pass 12.8 8.6 15.9 11.3 14.9 10.5 Dx
4.70 .011
.023 1-2 --Fail
17.0 2.8 22.1 10.0 14.1 9.5 WMT
1.35 .252
.003 1-3 --Interaction 2.62 .072
.013 2-3 -0.80
t
0.68
4.77
0.29
p
.503
<.01
.771
d
-0.58
-BRFail

9.1%

31.5%

21.4%

Note. WMT: Word Memory Test (dichotomous outcome based on standard cutoffs); ORTHO: Orthopedic injury; mTBI: Mild traumatic brain
injury; msTBI: Moderate-to-severe traumatic brain injury; Dx: Diagnosis of ORTHO, mTBI or msTBI group; BRFail : Base rate of failure (% of
the subsample that scored in the failing range); Dx: Diagnostic group; BDI-II: Beck Depression Inventory– Second Edition; Sig. post hocs:
Significant post hoc contrasts (uncorrected t-tests, p-value <.05).
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Table 2
Factorial ANOVA Examining the Effect of Diagnostic Group and WMT Outcome on Scores on the MMPI-II
Hs-Scale

Pass
Fail

Diagnostic Groups
1
2
ORTHO mTBI
n = 31
n = 339
M
SD M
SD
72.1 12.1 72.4 12.9
86.3 12.3 77.9 12.6

t
p
d

2.19
.037
1.16

3.64
<.001
0.43

n = 92
M
SD Effect
67.7 13.1 Dx
72.9 13.0 WMT
Interaction
1.47
.146
--

BRFail

12.9%

31.0%

19.6%

WMT

Outcome Measure
MMPI-2 Hs

3
msTBI

ANOVA
F
p
.014
4.34
10.01 .002
.466
0.76

Sig.
post
η2p
hocs
.019 1-2
.022 1-3
.003 2-3

Main Effect
Fail
Pass
d
d
----0.36
--

Note. WMT: Word Memory Test (dichotomous outcome based on standard cutoffs); ORTHO: Orthopedic injury;
mTBI: Mild traumatic brain injury; msTBI: Moderate-to-severe traumatic brain injury; Dx: Diagnosis of ORTHO,
mTBI or msTBI group; BRFail : Base rate of failure (% of the subsample that scored in the failing range); Dx:
Diagnostic group; MMPI-2: Minnesota Multiphasic Personality Inventory – Second Edition; Sig. post hocs: Signficant
post hoc contrasts (uncorrected t-tests, p-value <.05).
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Table 3
Factorial ANOVA Examining the Effect of Diagnostic Group and WMT Outcome on Scores on the MMPI-II
De-Scale

Pass
Fail

Diagnostic Groups
1
2
ORTHO mTBI
n = 31
n = 339
M
SD M
SD
69.6 15.6 68.6 14.5
76.5 18.9 75.9 12.9

t
p
d

0.81
.424
--

4.48
.010
0.46

n = 92
M
SD Effect
67.7 13.7 Dx
70.3 13.3 WMT
Interaction
0.74
.461
--

BRFail

12.9%

31.0%

19.6%

WMT

Outcome Measure
MMPI-2 De

3
msTBI

ANOVA
F
p
1.34 .263
3.93 .050
0.68 .507

Sig.
post
η2p
hocs
.006 1-2
.009 1-3
.003 2-3

Main Effect
Fail
Pass
d
d
-------

Note. WMT: Word Memory Test (dichotomous outcome based on standard cutoffs); ORTHO: Orthopedic injury;
mTBI: Mild traumatic brain injury; msTBI: Moderate-to-severe traumatic brain injury; Diagnosis of ORTHO, mTBI or
msTBI group; BRFail : Base rate of failure (% of the subsample that scored in the failing range); Dx: Diagnostic group;
MMPI-2: Minnesota Multiphasic Personality Inventory – Second Edition; Sig. post hocs: Signficant post hoc contrasts
(uncorrected t-tests, p-value <.05).
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Table 4
Factorial ANOVA Examining the Effect of Diagnostic Group and WMT Outcome on Scores on the MMPI-II
Hy-Scale

Pass
Fail

Diagnostic Groups
1
2
ORTHO mTBI
n = 31
n = 339
M
SD M
SD
72.0 14.5 71.4 14.9
94.8 10.7 77.1 16.5

t
p
d

3.00
.005
1.79

3.14
.002
0.36

n = 92
M
SD Effect
64.5 14.9 Dx
71.2 20.2 WMT
Interaction
1.61
.112
--

BRFail

12.9%

31.0%

19.6%

WMT

Outcome Measure
MMPI-2 Hy

3
msTBI

ANOVA
F
p
7.06 .001
14.0 <.001
2.03 .132

Sig.
post
η2p
hocs
.030 1-2
.030 1-3
.009 2-3

Main Effect
Fail
Pass
d
d
-1.27
0.51
1.46
0.46
--

Note. WMT: Word Memory Test (dichotomous outcome based on standard cutoffs); ORTHO: Orthopedic injury;
mTBI: Mild traumatic brain injury; msTBI: Moderate-to-severe traumatic brain injury; Diagnosis of ORTHO, mTBI or
msTBI group; BRFail : Base rate of failure (% of the subsample that scored in the failing range); Dx: Diagnostic group;
MMPI-2: Minnesota Multiphasic Personality Inventory – Second Edition; Sig. post hocs: Signficant post hoc contrasts
(uncorrected t-tests, p-value <.05).
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Table 5
Factorial ANOVA Examining the Effect of Diagnostic Group and WMT Outcome on Scores on the MMPI-II
Pd-Scale

Pass
Fail

Diagnostic Groups
1
2
ORTHO mTBI
n = 31
n = 339
M
SD M
SD
58.2 14.3 56.0 12.3
54.8 8.5 59.7 11.3

t
p
d

.471
.641
--

2.61
.010
0.31

n = 92
M
SD Effect
58.5 14.0 Dx
57.1 11.7 WMT
Interaction
.396
.693
--

BRFail

12.9%

31.0%

19.6%

WMT

Outcome Measure
MMPI-Pd

3
msTBI

Sig.
ANOVA
post
F
p
η2p
hocs
0.08 .924 <.001 1-2
0.02 .872 <.001 1-3
1.44 .239 .006
2-3

Main Effect
Fail
Pass
d
d
-------

Note. WMT: Word Memory Test (dichotomous outcome based on standard cutoffs); ORTHO: Orthopedic injury;
mTBI: Mild traumatic brain injury; msTBI: Moderate-to-severe traumatic brain injury; Diagnosis of ORTHO, mTBI or
msTBI group; BRFail : Base rate of failure (% of the subsample that scored in the failing range); Dx: Diagnostic group;
MMPI-2: Minnesota Multiphasic Personality Inventory – Second Edition; Sig. post hocs: Signficant post hoc contrasts
(uncorrected t-tests, p-value <.05).
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Table 6
Factorial ANOVA Examining the Effect of Diagnostic Group and WMT Outcome on Scores on the MMPI-2Pa- Scale

Pass
Fail

Diagnostic Groups
1
2
ORTHO mTBI
n = 31
n = 339
M
SD M
SD
56.7 17.5 57.0 14.1
56.0 10.0 60.7 15.1

t
p
d

0.07
.942
--

2.20
.028
0.25

n = 92
M
SD Effect
57.9 15.7 Dx
63.1 15.6 WMT
Interaction
1.27
.206
--

BRFail

12.9%

31.0%

19.6%

WMT

Outcome Measure
MMPI-Pa

3
msTBI

ANOVA
F
p
0.52 .594
0.84 .359
0.22 .800

Sig.
post
η2p
hocs
.002 1-2
.002 1-3
.001 2-3

Main Effect
Fail
Pass
d
d
-------

Note. WMT: Word Memory Test (dichotomous outcome based on standard cutoffs); ORTHO: Orthopedic injury;
mTBI: Mild traumatic brain injury; msTBI: Moderate-to-severe traumatic brain injury; Diagnosis of ORTHO, mTBI or
msTBI group; BRFail : Base rate of failure (% of the subsample that scored in the failing range); Dx: Diagnostic group;
MMPI-2: Minnesota Multiphasic Personality Inventory – Second Edition; Sig. post hocs: Signficant post hoc contrasts
(uncorrected t-tests, p-value <.05).
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Table 7
Factorial ANOVA Examining the Effect of Diagnostic Group and WMT Outcome on Scores on the MMPI-2 Sc
Scale

Pass
Fail

Diagnostic Groups
1
2
ORTHO mTBI
n = 31
n = 339
M
SD M
SD
65.2 15.2 64.6 15.5
64.3 7.8 72.7 13.4

t
p
d

0.12
.902
--

4.64
<.001
0.56

n = 92
M
SD Effect
65.8 16.0 Dx
69.2 17.0 WMT
Interaction
0.79
.427
--

BRFail

12.9%

31.0%

19.6%

WMT

Outcome Measure
MMPI-Sc

3
msTBI

ANOVA
F
p
0.53 .589
1.31 .253
1.09 .338

Sig.
post
η2p
hocs
.002 1-2
.003 1-3
.005 2-3

Main Effect
Fail
Pass
d
d
-------

Note. WMT: Word Memory Test (dichotomous outcome based on standard cutoffs); ORTHO: Orthopedic injury;
mTBI: Mild traumatic brain injury; msTBI: Moderate-to-severe traumatic brain injury; Diagnosis of ORTHO, mTBI or
msTBI group; BRFail : Base rate of failure (% of the subsample that scored in the failing range); Dx: Diagnostic group;
MMPI-2: Minnesota Multiphasic Personality Inventory – Second Edition; Sig. post hocs: Signficant post hoc contrasts
(uncorrected t-tests, p-value <.05).
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Table 8
Factorial ANOVA Examining the Effect of Diagnostic Group and WMT Outcome on Scores on the MMPI-II
Ma-Scale

Pass
Fail

Diagnostic Groups
1
2
ORTHO mTBI
n = 31
n = 339
M
SD M
SD
55.0 11.1 53.1 10.7
42.5 4.43 52.2 9.9

t
p
d

2.19
.037
1.48

.745
.457
--

n = 92
M
SD Effect
53.7 11.6 Dx
49.4 9.7 WMT
Interaction
1.43
.156
--

BRFail

12.9%

31.0%

19.6%

WMT

Outcome Measure
MMPI-2 Ma

3
msTBI

ANOVA
F
p
.341
1.08
.007
7.44
.093
2.39

Sig.
post
η2p
hocs
.005 1-2
.016 1-3
.010 2-3

Main Effect
Fail
Pass
d
d
-------

Note. WMT: Word Memory Test (dichotomous outcome based on standard cutoffs); ORTHO: Orthopedic injury;
mTBI: Mild traumatic brain injury; msTBI: Moderate-to-severe traumatic brain injury; Dx: Diagnosis of ORTHO,
mTBI or msTBI group; BRFail : Base rate of failure (% of the subsample that scored in the failing range); Dx:
Diagnostic group; MMPI-2: Minnesota Multiphasic Personality Inventory – Second Edition; Sig. post hocs: Signficant
post hoc contrasts (uncorrected t-tests, p-value <.05).

Cognitive Performance
Scores on neurocognitive measures were compared separately using one-way ANOVAs
to test for Dx and WMT group differences. A one-way ANOVA was used instead a 2- way
ANOVA given the limited sample size due to the inconsistently administered tests. Performing
factorial ANOVAs created cells with no participants. Performance on the CVLT 1-5 and CVLT
RH were significantly different between Dx (Table 9). Post hoc analyses revealed that the
msTBI group performed significantly worse on the CVLT 1-5 than the mTBI and orthopedic
groups (d: 0.31-0.50; small-medium effect). On the CVLT RH those in the mTBI and msTBI
group did significantly worse than the orthopedic group (d = 0.56; medium effect). There were
no other group differences on cognitive measures. Failing the WMT was associated with lower
scores on all neurocognitive tests (d: 0.68-0.98; medium-large effect) (Table 10).
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Table 9
One Way ANOVA Examining the Effect of Diagnostic Group on Scores on Cognitive Measures
Diagnostic Groups
1
2
ORTHO
mTBI
n = 38
n = 336
M
SD
M
SD
TMTA
47.1 12.5
46.8 11.8
TMTB
47.1 8.7
47.7 11.7
FTT
45.9 16.2
48.2 12.3
GPB
41.1 14.1
45.5 12.7
CVLT 1-5
51.0 9.9
49.3 11.8
3.1
10.1 3.5
CVLT LD-FR 10.4
CVLT RH
14.9 1.2
13.8 2.5

3
msTBI
n = 89
M
43.7
45.0
45.6
42.6
45.7
9.4
13.9

Sig. post hocs
SD
12.0
12.5
12.5
11.5
11.2
3.7
2.2

ANOVA
F
p
η2p
2.31 .100 .120
1.61 .202 .008
1.42 .243 .009
2.38 .094 .012
4.30 .014 .018
1.64 .194 .007
4.06 .018 .017

1-2
------0.56

1-3 2-3
--------0.50 0.31
--0.56
--

Note. ORTHO: Orthopedic injury; mTBI: Mild traumatic brain injury; msTBI: Moderate-to-severe traumatic brain injury;
Diagnosis of ORTHO, mTBI or msTBI group; Sample size fluctuated across measures (orthopedic: 11-38; mTBI: 235- 336;
msTBI: 79-89 n size fluctuate between tests; TMT Trail Making Test demographically adjusted T-score (Abeare et al., 2019;
Erdodi & Lichtenstein, 2020) based on norms by Heaton et al. (2004); FTT DH Finger Tapping Test dominant hand
demographically adjusted T-score (Erdodi et al., 2019b) based on norms by Heaton et al. (2004); GPB DH Grooved Pegboard
Test dominant hand demographically adjusted T-score (Erdodi et al., 2018c; Erdodi et al., 2017) based on norms by Heaton et al.
(2004); CVLT California Verbal Learning Test, 1–5: acquisition trials (sum of raw scores across trials 1 through 5; Curtis et al.,
2006; Millis et al., 1995; Shura et al., 2016; Trueblood, 1994); RH: Yes/No Recognition hits (true positives) raw score (Persinger
et al., 2018; Sweet et al., 2000; Trueblood, 1994; Wolfe et al., 2010); Sig. post hocs: Signficant post hoc contrasts (uncorrected t-tests,
p-value <.05).
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Table 10
Examining the Effect of Word Memory Test Pass/Fail on Cognitive Measures

TMTA
TMTB
FTT
GPB
CVLT 1-5
CVLT LD-FR
CVLT RH

Word Memory Test
Pass
Fail
n = 335
n = 127
M
SD
M
SD
48.3 11.2 40.5 11.7
49.2 10.5 40.9 12.8
49.5 11.1 41.6 12.5
47.0 12.4 38.7 10.8
51.5 10.5 41.5 11.4
10.9 3.2
7.7
3.3
14.5 1.7
12.2 3.1

t
6.14
6.62
5.33
5.97
8.90
9.26
10.2

p
<.001
<.001
<.001
<.001
<.001
<.001
<.001

d
0.68
0.71
0.67
0.71
0.91
0.98
0.92

Note. WMT: Word Memory Test (dichotomous outcome based on standard cutoffs); Sample size fluctuated across
measures (pass: 246-335; fail: 79-127); TMT Trail Making Test demographically adjusted T-score (Abeare et al., 2019;
Erdodi & Lichtenstein, 2020) based on norms by Heaton et al. (2004); FTT DH Finger Tapping Test dominant hand
demographically adjusted T-score (Erdodi et al., 2019b) based on norms by Heaton et al. (2004); GPB DH Grooved
Pegboard Test dominant hand demographically adjusted T-score (Erdodi et al., 2018c; Erdodi et al., 2017c) based on
norms by Heaton et al. (2004); CVLT California Verbal Learning Test, 1–5: acquisition trials (sum of raw scores across
trials 1 through 5; Curtis et al., 2006; Millis et al., 1995; Shura et al., 2016; Trueblood, 1994); RH: Yes/No Recognition
hits (true positives) raw score (Persinger et al., 2018; Sweet et al., 2000; Trueblood, 1994; Wolfe et al., 2010);

Performance vs Symptom Validity across Diagnosis
A chi-squared test of independence was calculated to compare group membership across
PVT and SVT outcomes (Pass/Fail status). Failing the MMPI F scale and the WMT were
unrelated in the overall sample (Table 11). As previously mentioned, failing the PVT was related
to Dx and those with mTBI group failed the WMT at a higher rate compared to msTBI group but
not when compared to the orthopedic group. MMPI F scale Pass/Fail status was unrelated to
group membership χ2 (2, N = 480) = 1.63, p = .444, Φ2 = .003 (small effect). However, there was
a significant relationship between passing and failing the MMPI F scale within the mTBI group
(small effect).
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Table 11
Examining Word Memory Test and Minnesota Multiphasic Personality Inventory F- Scale Across Injury Severity

ORTHO
n = 41
WMT
Pass
Fail
χ2
p
Φ2
RR

Pass Fail
28
5
6
2
.441
.507
.011
1.14

Diagnostic Groups
mTBI
mod-sevTBI
n = 345
n = 93
MMPI-2 F
Pass Fail
Pass Fail
188 68
55
20
50
39
13
5
9.19
.002
.027
0.83

Contrasts
χ
p
Φ2
1.99
.370
.005
.858
.651
.006
2

.009
.924
<.001
0.72

Note. WMT: Word Memory Test (standard cutoffs); MMPI-2: Minnesota Multiphasic Personality Inventory –
Second Edition; F: F Scale (Fail defined as T > 70); ORTH: Orthopedic injury; mTBI: Mild traumatic brain
injury; mod-sevTBI: Moderate-to-severe traumatic brain injury; RR: Risk ratio.

CHAPTER 4
Discussion
PVT failure has previously been shown to vary based on injury severity level, with mTBI
paradoxically having the highest BRFail (Donders, Lefebre & Goldsworthy, 2019; Abeare et al.,
2019; Carone, 2008; Erdodi & Rai, 2017; Green, Flaro, & Courtney, 2009; Green, Iverson &
Allen, 1999). There is accumulating evidence of a positive relationship between BRFail and selfreported psychiatric symptoms (Erdodi et al., 2017; Miskey et al., 2019). The objective of the
current study was to determine if patients with mTBI who fail PVTs have higher psychiatric
symptom reporting than those in other Dx groups, taking symptom validity into account, and
thus offer a potential explanation for the inverse dose-response relationship between Dx and
BRFail.
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As predicted, WMT failure differed across Dx groups with those in the mTBI group
failing more than those with msTBI. Consistent with the hypotheses, BRFail differed across Dx,
driven by the significantly higher BRFail within the mTBI sample. Participants who failed the
WMT had significantly higher levels of self-reported psychopathology on the MMPI-2 Hy, De,
Hs, Ma scales. This finding is consistent with previous reports of a link between psychiatric
symptom reporting and PVT failure (Erdodi et al., 2017; Marcopulos et al., 2014; Miskey et al.,
2019). In particular, the Hy, De, and Hs scales on the MMPI-2 have been cited as related to PVT
failure in the context of the “conversion V pattern” (Boone & Lu, 1999). This pattern indicates
elevations on Hy and Hs scales with a lower De score, interpreted as a tendency to express
emotional difficulties as somatic symptoms. In the current findings, however, the De scale was
also elevated along with the Hy and Hs scales. It is unclear in the literature if a lower De scale is
necessary for this link between psychiatric symptoms and PVT failure. Some authors suggest any
source of evidence that PVT failure is linked with higher levels of self-reported symptoms is
supportive of the psychogenic interference hypothesis (Erdodi et al., 2016; Erdodi et al., 2018).
Therefore these findings suggest that having all three scales elevated may also be linked to PVT
failure.
There was also support for a relationship between Dx and psychiatric symptom reporting.
Significant main effects for Dx emerged for BDI-II, MMPI-2 Hy and Hs scales. Much of this
effect appeared to be driven by the differences between mTBI and msTBI groups. Notably, there
was no effect of Dx on the De or Pa scales which has been shown between mTBI and msTBI
groups in previous research (Gass & Russell, 1991;Youngjohn, Davis, & Wolf, 1997). However,
the orthopedic group was significantly higher on the Hy scale than the other diagnostic groups.
Although non-significant in post hoc contrasts, patients who failed WMT within the orthopedic
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group also scored higher on MMPI-Hy. It has been shown that individuals seeking treatment for
medical diagnoses (i.e., orthopedic injuries) are often elevated on these two MMPI-2 scales, and
this high elevation can be indicative of functional factors maintaining somatic symptoms
(Graham, 2000). Characteristics of those with orthopedic injuries who require psychiatric/
neuropsychological assessment may contribute to an increased levels of distress, or increased
risk of non-credible presentation in this sample as compared to those with TBI.
Interestingly, there was no evidence of an interaction effect of Dx and PVT on
psychiatric symptom elevations. This finding is counter to the support provided by previous
studies that have linked increased PVT failure to those with higher psychiatric symptoms and
TBI (Erdodi et al., 2016; Erdodi et al., 2018; Greiffenstein & Baker, 2008; Clark et al., 2014).
However, there are notable design differences between the present study and previous literature
on the topic. For example, in this sample self-reported symptom elevation was used instead of
diagnosed disorders which may have not have been pervasive enough to interfere with PVT
outcome. In addition, only one PVT was used. Although it is a highly sensitive PVT, in isolation
it likely has poorer sensitivity than studies that used multiple PVTs.
There were also differences between two scales that measure symptoms of depression,
the BDI-II and the MMPI-2 De scale. Previous research has shown that the MMPI-2 De scale is
much more sensitive to depressive symptoms than the BDI-II (Burneo et al., 2016). This
sensitivity could have conflated depressive symptomatology reporting across the groups,
potentially minimizing any organic group effects in depression reporting. Alternatively, when
removing those who failed the SVT (MMPI-F scale) the main effect of Dx disappeared for the
BDI-II. This finding is consistent with literature comparing the two depression scales that has
shown the BDI-II scores are often predicted by over-reporting scales, meaning that BDI-II scores
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may be contaminated by symptom exaggeration (Burneo et al., 2016) and should be interpreted
in the context of SVT.
Cognitive Performance
Another surprising finding was that neurocognitive test scores did not follow the
predicted Dx gradient. The only measures that showed a significant difference among Dx were
CVLT 1-5 and RH trials. This finding is counter to what has been demonstrated in previous
studies (Green, 2007; Rohling et al., 2003) which may be due to sample-specific findings. For
instance, in this study there was no distinction made between mild uncomplicated TBI and a
more severe injury mild complicated TBI. Given that the sequalae of mcTBI more closely
resemble those of MTBI, the lack of distinction could have deflated the mean and inflated SDs
on cognitive test scores in this group, thereby obscuring the expected Dx group effect.
Additionally, the MTBI and STBI were also combined, washing away between-group
differences that could have otherwise been detected if there were greater distinction made
between injury severity level. Also, BRFail in the orthopedic group did not differ significantly
from the mTBI group which may explain why their cognitive test performance was poorer
overall.
Contrary to our assumption that the orthopedic group in this sample would be a suitable
control, the subset of individuals within the sample had some unexpected characteristics. For
example, they often reported higher levels of some psychiatric symptoms or performed poorly on
cognitive measures compared to those in the mTBI or msTBI groups. This finding highlights a
potential selection bias: patients with orthopedic injuries were likely referred for
neuropsychological testing due to complicated/atypical recovery. This suggests that these

39

patients were likely experiencing some sort of psychiatric and/or cognitive which may have
influenced their cognitive, psychiatric, and PVT outcomes.
There was a significant difference in cognitive measures as a function of PVT outcome.
Those who failed the WMT performed significantly worse on every cognitive measure. This
relationship was expected as previous research has shown those who perform poorly on PVTs
often have poorer outcomes across a broad range of cognitive tests (Constantinou et al., 2005;
Meyers et al., 2011; West et al., 2011). Performance validity often serves as a transdiagnostic
factors as it explains a higher percentage of cognitive test scores regardless of clinical
characteristics.
Clinical Implications
Although no interaction between Dx and WMT failure emerged, PVT failure was related
to increased levels of self-reported psychopathology on some MMPI-2 subscales. Patients with
mTBI reported more symptoms of depression, hypochondriasis, and hysteria than those in the
msTBI group. However, other MMPI-2 subscales did not show a link and the Dx groups did not
always behave in the predicted manner as the orthopedic group was higher than both mTBI and
msTBI groups on the Hy scale. The unpredicted outcome regarding the orthopedic group serves
as an important reminder that “reason for referral” or “main Dx” are heterogeneous categories
with highly variable clinical characteristics.
The psychogenic interference hypothesis was possibly supported as failing the PVT was
related to higher symptom reporting on the Hs, De, Hy, and Ma scales. This pattern of findings
may be useful to determine potential mechanisms behind PVT failure. Elevations on the these
scales for those who failed the WMT may suggest that certain clinical characteristics such as
being overly concerned with their health, anxiety and stress, low mood, or mania may be linked
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to PVT failure. Whether this is a causal relationship or not is an important detail that is beyond
the scope of the present investigation.
Results for Dx and WMT Pass/Fail outcomes were consistent even after removing those
who failed SVTs, except for the effect of Dx on BDI-II. Due to the high transparency of the test
items on the BDI-II, it is possible that patients found it easier to overreport symptoms on this
scale. In other words, it is likely that the effect of PVT failure on BDI-II symptom reporting was
due to symptom over-reporting and not genuine psychopathology. Lastly, PVT and SVT
outcomes were unrelated, which further supports the concept of domain specificity and the need
to independently assess both cognitive performance validity as well as self-reported symptom
validity (Armistead-Jehle et al., 2020).
Overall, these findings are important for clinicians to consider in their practice when
designing their test batteries and interpreting test scores. Knowing that some individuals with
certain cluster of psychiatric symptoms are more likely to fail PVTs (and therefore, produce
lower scores on measures of cognitive ability) may encourage the clinician to be aware of these
factors prior to neuropsychological assessment to get the most accurate performance from the
patient. Also, these results should encourage clinicians to include PVTs and SVTs in their
batteries even when the patient does not necessarily belong to a clinical population that has been
previously shown to be susceptible to PVT or SVT failure.
Limitations and Future Direction
The most significant limitations of this study stem from the lack of critical information
due to the use of archival data. Multiple variables that would have helped the analyses by
controlling for them were not available for analysis. For example, information on litigation
status/external incentive was not available. This information is valuable as litigation status is
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often related to PVT failure which could offer another potential link between mTBI and high
PVT failure rates. Additionally, information on participant’s premorbid psychiatric history was
unavailable which has been more directly linked to elevated PVT failure in patients with TBI in
previous studies (Armistead-Jehle, 2010; Miskey et al., 2020). Future research should control
for these confounding factors to isolate their influence on PVT outcome. Another limitation of
this dataset was the classification of TBI severity groups. Previous research investigating the
MMPI-2 scales across brain injury severity indicates that mTBI and MTBI groups often have
higher elevations on the Hy, De, and Hs scales than those with severe TBI (Ferguson &
Mittenberg, 1995; Mittenberg et al., 1992; Youngjohn et al., 1997). In the archival dataset
utilized in this study there was no distinction made between moderate and severe TBI meaning
that some of the distinctions between those groups may have been underreported because of this.
Also, traditionally STBI patients are less likely to require medicolegal evaluations which may
have further obscured this Dx group differences by creating unrepresentative samples of Dx.
Future research should increase the purity of criterion groups in order to tease apart these
differences. This sample was also taken from one Canadian city and their psychiatric diagnoses
were not known. Therefore, these results may not generalize to different geographic
(Lichtenstein et al., 2019) or clinical (Glassmire et al., 2019) populations. Additionally,
limitations of sample size underpowered the interaction analyses due to small group size –
particularly the orthopedic PVT failure group. Lastly, only one PVT and SVT were used for
classification which may have created issues with instrument artifacts. Future research should
inspect this phenomenon using multiple different PVTs.
In summary, this study evaluated psychiatric symptom reporting across PVT outcome
and TBI injury severity levels. Although no link between PVT outcome and Dx was found in
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terms of self-reported psychiatric symptoms, each factor independently explained a significant
amount of variance of psychiatric self-reporting. Future research expanding this study with
different PVTs, incorporating information on premorbid psychiatric history, and distinguishing
between moderate and severe TBI is warranted.
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Appendix
Table 1. Glasgow Coma Scale
Response
Eye Opening Response

Verbal Response

Motor Response

Scale

Score

Open spontaneously

4

Open to verbal command, speech, or shout

3

Open to pain (not applied to face)

2

Do not open

1

Oriented

5

Confused conversation, can answer questions

4

Inappropriate response, words dissemble

3

Incomprehensible sounds or speech

2

No verbal response

1

Obeys commands for movement

6

Purposeful movement to painful stimulus

5

Withdraws from pain

4

Abnormal (spastic) flexion; decorticate posture

3

Extensor (rigid) response; decerebrate posture

2

No motor response

1
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Table 2. Classification of Brain Injury by the American Congress of Rehabilitation
Medicine
Injury Severity

LOC

GCS

PTA

Mild

LOC < 30 minutes

13-15

PTA< 24 hours

Moderate

30 minutes > LOC> 24 hours

9-12

24 hours > PTA > 7 days

Severe

LOC> 24 hours

3-8

PTA > 7 days
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